Poseida Therapeutics Inc (PSTX)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.86
+0.13
(+4.76%)
After-Hours: 20:00
Poseida Therapeutics Debt to Equity Ratio: 0.6755 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.6755 |
| June 30, 2024 | 0.9668 |
| March 31, 2024 | 0.6938 |
| December 31, 2023 | 0.565 |
| September 30, 2023 | 0.473 |
| June 30, 2023 | 0.4316 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.3701 |
| December 31, 2022 | 0.3105 |
| September 30, 2022 | 0.2689 |
| June 30, 2022 | 0.8824 |
| March 31, 2022 | 0.559 |
| December 31, 2021 | 0.1879 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1879
Minimum
Dec 2021
0.9668
Maximum
Jun 2024
0.532
Average
0.516
Median
Debt to Equity Ratio Benchmarks
| Organogenesis Holdings Inc | 0.223 |
| MaxCyte Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 293.58M |
| Total Liabilities (Quarterly) | 206.37M |
| Shareholders Equity (Quarterly) | 87.21M |
| Current Ratio | 3.203 |
| Net Debt Paydown Yield | -0.04% |